Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological chaperoning: A primer on mechanism and pharmacology
Nancy J. Leidenheimer, Katelyn G. Ryder
Pharmacological Research (2014) Vol. 83, pp. 10-19
Open Access | Times Cited: 90

Showing 26-50 of 90 citing articles:

Pharmacological chaperones of ATP-sensitive potassium channels: Mechanistic insight from cryoEM structures
Gregory Martin, Min Woo Sung, Show‐Ling Shyng
Molecular and Cellular Endocrinology (2019) Vol. 502, pp. 110667-110667
Open Access | Times Cited: 32
How to rescue misfolded SERT, DAT and NET: targeting conformational intermediates with atypical inhibitors and partial releasers
Shreyas Bhat, Amy Hauck Newman, Michael Freissmuth
Biochemical Society Transactions (2019) Vol. 47, Iss. 3, pp. 861-874
Open Access | Times Cited: 30
Odorants have the potential to enhance the heterologous expression of human olfactory receptors: evidence from ethyl 3-phenylglycidate and its effects on OR1A1, OR11G2, and OR2W1
Ichie Ojiro, Ryusei Kaneko, Takahiro Kashiwagi, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 752, pp. 151459-151459
Closed Access
AI-based discovery and cryoEM structural elucidation of a KATP channel pharmacochaperone
Assmaa ElSheikh, Camden Driggers, Ha H. Truong, et al.
eLife (2025) Vol. 13
Open Access
Molecular Basis of the Dominant Negative Effect of a Glycine Transporter 2 Mutation Associated with Hyperekplexia
Esther Arribas-González, Jaime de Juan‐Sanz, Carmen Aragón, et al.
Journal of Biological Chemistry (2014) Vol. 290, Iss. 4, pp. 2150-2165
Open Access | Times Cited: 30
Rescue of protein expression defects may not be enough to abolish the pro‐arrhythmic phenotype of long QT type 2 mutations
Matthew D. Perry, Chai‐Ann Ng, Kevin Phan, et al.
The Journal of Physiology (2016) Vol. 594, Iss. 14, pp. 4031-4049
Open Access | Times Cited: 29
HumanRECQHelicase Pathogenic Variants, Population Variation and “Missing” Diseases
Wenqing Fu, Alessio Ligabue, Kai J. Rogers, et al.
Human Mutation (2016) Vol. 38, Iss. 2, pp. 193-203
Open Access | Times Cited: 29
New insights into the role of the Golgi apparatus in the pathogenesis and therapeutics of human diseases
Wooseon Choi, Shin-Won Kang, Jiyoon Kim
Archives of Pharmacal Research (2022) Vol. 45, Iss. 10, pp. 671-692
Closed Access | Times Cited: 15
Regulation of nicotinic acetylcholine receptors in Alzheimer׳s disease: A possible role of chaperones
Saeed Sadigh‐Eteghad, Alireza Majdi, Mahnaz Talebi, et al.
European Journal of Pharmacology (2015) Vol. 755, pp. 34-41
Closed Access | Times Cited: 26
Repairing folding-defective α-sarcoglycan mutants by CFTR correctors, a potential therapy for limb-girdle muscular dystrophy 2D
Marcello Carotti, Justine Marsolier, Michela Soardi, et al.
Human Molecular Genetics (2018) Vol. 27, Iss. 6, pp. 969-984
Open Access | Times Cited: 24
Targeting trafficking as a therapeutic avenue for misfolded GPCRs leading to endocrine diseases
Alfredo Ulloa‐Aguirre, Teresa Zariñán, Rubén Gutiérrez‐Sagal, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 13
The Molecular Basis of Oligomeric Organization of the Human M3Muscarinic Acetylcholine Receptor
María José Varela Liste, Gianluigi Caltabiano, Richard J. Ward, et al.
Molecular Pharmacology (2015) Vol. 87, Iss. 6, pp. 936-953
Open Access | Times Cited: 24
Investigation of original multivalent iminosugars as pharmacological chaperones for the treatment of Gaucher disease
Eugénie Laigre, Damien Hazelard, Josefina Casas, et al.
Carbohydrate Research (2016) Vol. 429, pp. 98-104
Closed Access | Times Cited: 23
Non-neuronopathic lysosomal storage disorders: Disease spectrum and treatments
Gregory M. Pastores, Derralynn Hughes
Best Practice & Research Clinical Endocrinology & Metabolism (2014) Vol. 29, Iss. 2, pp. 173-182
Closed Access | Times Cited: 22
Galactosemia: Towards Pharmacological Chaperones
Samantha Banford, Thomas J. McCorvie, Ángel L. Pey, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 2, pp. 106-106
Open Access | Times Cited: 16
Chaperoning of the A1-Adenosine Receptor by Endogenous Adenosine—An Extension of the Retaliatory Metabolite Concept
J.C. Kusek, Qiong Yang, Martin Witek, et al.
Molecular Pharmacology (2014) Vol. 87, Iss. 1, pp. 39-51
Open Access | Times Cited: 19
Neuronal gamma-aminobutyric acid (GABA) type A receptors undergo cognate ligand chaperoning in the endoplasmic reticulum by endogenous GABA
Ping eWang, Randa S. Eshaq, Charlie K. Meshul, et al.
Frontiers in Cellular Neuroscience (2015) Vol. 9
Open Access | Times Cited: 18
Structure-Activity Relationships of Dopamine Transporter Pharmacological Chaperones
Charles Sutton, Erin Q. Williams, Hoomam Homsi, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 10
Hepatic steatosis after islet transplantation: Can ultrasound predict the clinical outcome? A longitudinal study in 108 patients
Massimo Venturini, Paola Maffi, Giuseppe Querques, et al.
Pharmacological Research (2015) Vol. 98, pp. 52-59
Closed Access | Times Cited: 16
Assessment of G Protein-Coupled Oestrogen Receptor Expression in Normal and Neoplastic Human Tissues Using a Novel Rabbit Monoclonal Antibody
Maria Bubb, Anna-Sophia Lieselott Beyer, Pooja Dasgupta, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5191-5191
Open Access | Times Cited: 9
Pharmacological Chaperones: Beyond Conformational Disorders
Nancy J. Leidenheimer
Handbook of experimental pharmacology (2017), pp. 135-153
Closed Access | Times Cited: 15
Allosteric Modalities for Membrane-Bound Receptors: Insights from Drug Hunting for Brain Diseases
Quinn Coughlin, Allen T. Hopper, Marı́a-Jesús Blanco, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 13, pp. 5979-6002
Closed Access | Times Cited: 15
A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria
Helene J. Bustad, Karen Toska, Caroline Schmitt, et al.
Molecular Therapy (2019) Vol. 28, Iss. 2, pp. 677-689
Open Access | Times Cited: 14
Rescue of Cell Surface Expression and Signaling of Mutant Follicle-Stimulating Hormone Receptors
Sharika Hanyroup, Ross C. Anderson, Selvaraj Nataraja, et al.
Endocrinology (2021) Vol. 162, Iss. 12
Open Access | Times Cited: 12
Evaluation of pharmacochaperone-mediated rescue of mutant V2 receptor proteins
Beril Erdem Tuncdemir, Hatice Mergen, Emel Sağlar Özer
European Journal of Pharmacology (2019) Vol. 865, pp. 172803-172803
Closed Access | Times Cited: 12

Scroll to top